Caribou Biosciences, Inc.
Clinical trials sponsored by Caribou Biosciences, Inc., explained in plain language.
-
Gene-Edited immune cells aim to tame tough lupus
Disease control TerminatedThis study planned to test a single infusion of CB-010, a CRISPR-edited immune cell therapy, in people with severe lupus that did not respond to standard treatments. The goal was to see if it is safe and can control the disease. However, the study was withdrawn before any partici…
Phase: PHASE1 • Sponsor: Caribou Biosciences, Inc. • Aim: Disease control
Last updated May 17, 2026 16:24 UTC
-
15-Year safety check for caribou cell therapy patients
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows about 150 people who have already received Caribou cell therapy for blood cancers like lymphoma or leukemia. The goal is to track any long-term side effects for up to 15 years after treatment. No new treatments are given—just regular check-ups to monitor safety…
Sponsor: Caribou Biosciences, Inc. • Aim: Knowledge-focused
Last updated May 13, 2026 16:01 UTC